FDA Investigator Edward Oshaughnessy
Edward Oshaughnessy has inspections in 17 countries as of 13 Oct 2023. Edward Oshaughnessy has collaborated with a combinined 3194 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
339
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India,
Canada,
Bulgaria,
Jamaica,
China,
Malaysia,
Belgium,
United Kingdom of Great Britain and Northern Ireland,
Trinidad and Tobago,
Turkey,
Viet Nam,
Peru,
Japan,
Germany,
Mexico
Co-Investigator(s):
A Williams,
Albert M Brindle,
Althea A Williams,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Ana S Cabrera,
Anastasia I Offordile,
Andrew F Cohen,
Annemarie Bodnar,
Annemarie Kleiza,
Anthony M Criscuolo, Jr,
Antoinette L Ravelli,
Arduino Frankovic,
Arlyss M Jones,
Atul J Agrawal,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Brian D Young,
Brian R Yaun,
Brian Ravitch,
Byungja E Marciante,
Carol A Perry,
Carol A Robles,
Cary Greene,
Charisse K Green,
Charles J Chacko,
Charles M Edwards,
Charlotte P Chang,
Cherie T Parker,
Christina N Maurino,
Craig W Swanson,
David A Schwartz,
David G Whitman,
David H Smith,
David J Leray,
Dawn L Wydner,
Dena M Elimam,
Denise M Visco, Investigator,
Dennis L Doupnik,
Derek S Dealy,
Dessa A Antoine,
Devon Jenkins,
Dhaval H Patel,
Diana K Krepel,
Doreen P Gubbay,
Dorothy J Denes,
Edith M Gonzalez,
Edward O'shaughnessy,
Edward O'shaugnessy,
Elizabeth D Connell,
Elizabeth P Mayer,
Emest F Bizjak,
Emmanuel J Ramos,
Eric Rothschild,
Esteban Beltran,
Felix Maldonado,
Frank J Marciniak,
Frederick Razzaghi,
Gale L Glinecki,
Gianine E Delade,
Gianine E Tompkins,
Gobiga Vanniyasingam,
Grant L Davis,
Harperd,
Herrmann,
Hitesh R Patel,
Huy T Pham,
Jacqueline A O'shaughnessy, PhD,
James R Birkenstamm,
Janaye A Young,
Jane Chen,
Jason M Sluzynski,
Jason P Aun,
Jean M Kelahan,
Jennifer A Bazergui,
Jennifer A Robinson,
Jennifer L Custodio,
Jennifer Macmillan,
Jennifer R Mathern,
Jessica M Monteiro,
Jo Annc Declement,
Jonathan T Little,
Jonee J Mearns,
Jose M Cayuela,
Jose R Hernandez,
Joseph Duca,
Juan D Lopez,
Judith A Jones,
Judith A Paterson,
Justine Tomasso,
K Gonzlez,
Karen F Tomaziefski,
Karen M Labounty,
Karla J Gibler,
Kathleen J Close,
Keith A Schwartz,
Kelli A Giannattasio,
Kelli F Dobilas,
Kelly Doremus,
Kelly I Anderson,
Kenneth Nieves,
Kerry A Kurdilla,
King,
Kinh Q Mac,
Kris K Moore,
Kristen E Rescigno,
Kristy A Zielny,
Kyle D Covill,
Laishan L Lam,
Larry K Austin,
Lata C Mathew, PhD,
Lauren E Sexton,
Lauren L Vajo,
Lawrence R Johnson,
Li Li,
Lisa B Hall,
Lisa Mathew,
Lorna F Jones,
LT Luis O Rodriguez,
LTJG Matthew R Palo,
Marcellinus D Dordunoo,
Marcelo O Mangalindan, Jr,
Maria Estrella,
Marjorie D Schultz,
Matthew A Johnson,
Megan E Kerry,
Megan E Kulas,
Melissa A Freeman,
Melissa A Zuppe,
Melissa B Libby,
Melissa T Roy,
Melka F Argaw,
Meredith L Sheridan,
Meyer,
Michael E Campbell,
Michael Rosner,
Michael Serrano,
Michelle M Parisi,
Mielziner,
Mohammed H Adam,
Monica L Guitierrez,
Monica L Gutierrez,
Msdap Gonzlezk,
Nancy F Scheraga,
Neal D Singletary, PhD,
Nerizza B Guerin,
Nianna C Burns,
Nicholas A Violand,
Pedro A Cruz,
Peter M Trunk,
Phal K Chhun,
Ramanda C Gregory,
Raymond L Cheung,
Regina T Brown,
Remache,
Rene M Amaguana,
Richard D Manney,
Robert G Ruff,
Robert W Calais,
Rodrigo Vilchez,
Rupa Pradhan,
Saleem A Akhtar,
Sandra Kershaw,
Sands,
Sarah Forney,
Schultz,
Sean D Duke,
Sean G Casey,
Seng Ching Hwang,
Sherri J Liu,
Sinai Davis,
Sonia D Hudson,
State Agency,
Stephanie T Durso,
Steven S Wahl,
Susan M Halsted,
Tegan M Vanartsdalen,
Teigan M Mule,
Thomas J Hudson,
Tracy M Portelli,
Tressa T Lewis,
Valerie C Reed,
Wayne J Meyer,
William J Muszynski,
William W Dotts,
Young M Yoon,
Zakaria I Ganiyu
Edward Oshaughnessy's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2002 | FDA 483 Response | Ethicon, Inc. - Form 483R, 2002-03-25 |
| April, 2003 | EIR | Zebu Enterprises, LLC - EIR, 2003-04-30 |
| September, 2010 | FDA 483 | Vita Pure, Inc. - Form 483, 2010-09-23 |
| March, 2002 | EIR | Ethicon, Inc. - EIR, 2002-03-25 |
| September, 2011 | FDA 483 | Beaver-Visitec International, Inc. - Form 483, 2011-09-16 |
| May, 2014 | FDA 483 | Flawless Beauty LLC - Form 483, 2014-05-16 |
| December, 2003 | EIR | Arctic Products Company Inc. - EIR, 2003-12-11 |
| April, 2003 | FDA 483 | Zebu Enterprises, LLC - Form 483, 2003-04-30 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more